AMRX
AMRX
NASDAQ · Pharmaceuticals

Amneal Pharmaceuticals Inc

$16.11
-0.10 (-0.62%)
As of Jun 22, 9:54 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +617.2% upside
Low Target $65.43
Average Target $115.54
High Target $156.42
Current Price $16.11
Current
$16.11
Target
$115.54
$65.43 $115.54 avg $156.42
Scenario Analysis
Bear Case
$65.43
306.1%
Low target
Base Case
$115.54
+617.2%
Avg target
Bull Case
$156.42
+870.9%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$16.61
-3.0% from high
52-Week Low
$7.67
+110.2% from low
50-Day SMA
$13.39
+20.3% vs SMA
200-Day SMA
$10.30
+56.4% vs SMA
RSI (14)
57.4
Neutral
Target vs 52W High
$115.54
+595.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.7%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +29.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +37.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +35.2%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +219.0%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +176.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -32.3%